Molecular Imaging: Page 8

Telix highlights first patient dosed with new renal cancer PET agent
By AuntMinnieEurope.com staff writers
Telix Pharmaceuticals is highlighting that the first patient has been dosed with the company's TLX250-CDx for clear cell renal cell carcinoma.
December 4, 2023
Kidneys Closeup
Bayer reports results of phase II gadoquatrane clinical trial at RSNA
By AuntMinnieEurope.com staff writers
Bayer presented positive results of its phase II clinical trial of macrocyclic gadolinium-based compound gadoquatraine in a scientific session at RSNA 2023.
November 29, 2023
Bayer Rsna 2019 400
PET tracer shows promise in prostate cancer patients
By Will Morton
Gallium-68 RM2-PET/MRI is better than MRI alone for detecting relapse in prostate cancer patients, researchers have told attendees at RSNA 2023.
November 27, 2023
2023 11 27 Prostate Cancer Pet Tracer
Advanced imaging comes of age in brain cancer treatment
By Philip Ward
The use of advanced imaging techniques in brain cancer treatment is evolving fast, particularly in evaluating the use of radiotracers in glioblastoma cases, a new study shows.
November 22, 2023
An overview of all radiation oncology target volume delineations on axial imaging. Each row represents the benchmarking cases: FET-PET11 case 1 (a), FET-PET1 case 2 (b), and FET-PET1 case 3 (c). Shown here are standard gross tumor volume MRI (GTVMR, red), clinical target volume MRI (CTVMR, green), planning target volume MRI (PTVMR, orange), and hybrid GTVMR+FET (blue), CTVMR+FET (purple), PTVMR+FET (yellow). For comparison, GTVMR and GTVMR+FET are shown together with contrast-enhanced T1-weighted imaging, T2/FLAIR, and FET-PET. All images are co-registered to each case; respective planning CT where TVMR and TVMR+FET are displayed separately. Figure courtesy of Nathaniel Barry et al and presented at RANZCR ASM 2023.
FAPI-PET shows promise for detecting pancreatic cancer
By Will Morton
FAPI-PET imaging looks set to become a powerful diagnostic tool for detecting pancreatic cancer. That's the view of authors from University Hospital Essen in Germany.
November 21, 2023
2023 11 20 Fapi Pancreatic
Team Parizel/Francis opens imaging facility in Western Australia
By AuntMinnieEurope.com staff writers
ESR past president Prof. Paul Parizel, PhD, nuclear medicine physician Ros Francis, PhD, and colleagues have opened an advanced imaging facility in Western Australia. Over 200 people attended the recent official launch event.
November 8, 2023
2018 07 20 22 27 4483 Australian Flag 400
German study shines light on optimum use of PET in Alzheimer's
By Will Morton
A research group at the University of Munich has used PET imaging to reveal brain pathology linked to faster clinical progression of Alzheimer’s disease in patients with ApoE4 gene variants.
November 8, 2023
2017 04 14 16 09 55 745 Amyloid Plaque Alzheimer 400
EANM restructures and revises statutes
By AuntMinnieEurope.com staff writers
The European Association of Nuclear Medicine (EANM) has updated and revised its statutes to reflect the evolving needs of the association's membership.
November 5, 2023
2018 12 11 00 02 7009 Atom Nuclear Lab 400
United installs PET/CT scanner in Bologna
By AuntMinnieEurope.com staff writers
United Imaging Healthcare Europe has highlighted that the St. Orsola University Hospital in Bologna, Italy, is integrating the company's uMI Vista PET/CT system into the facility's medical oncology unit.
October 26, 2023
Pediatric PET radiotracer doses drop by a third over two decades
By Will Morton
Over the past 20 years, children have benefited from a massive reduction in PET imaging radiotracer doses without compromising image quality, according to researchers in Switzerland.
October 22, 2023
2020 10 20 23 49 8936 3 D Rendered Pet Machine 400
Does a novel PET system for prostate cancer have real clinical potential?
By Will Morton
A recently built dedicated PET scanner may improve the detection of prostate cancer and could ultimately reduce invasive patient biopsies to confirm disease, according to a research team in Bologna, Italy.
October 15, 2023
GE HealthCare and Sofie sign deal to develop FAPI-PET tracers
By AuntMinnieEurope.com staff writers
GE HealthCare has established a licensing agreement to commercialize two fibroblast activated protein inhibitor (FAPI)-PET radiotracers developed by Sofie Biosciences for cancer imaging.
October 12, 2023
Previous Page
Page 8 of 120
Next Page